Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Fever Rates in Children Ages 24 to 59 Months After Live Attenuated Influenza Vaccine (LAIV) or Inactivated Influenza Vaccines (IIV) Using Text Messaging for U.S. Influenza Vaccines in 2012-2013 & 2013-2014

NCT01764269 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT01764269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01764269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Fever Rates in Children Ages 24 to 59 Months After Live Attenuated Influenza Vaccine (LAIV) or Inactivated Influenza Vaccines (IIV) Using Text Messaging for U.S. Influenza Vaccines in 2012-2013 & 2013-2014
Lead sponsor
Columbia University
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2013
Completion date
May 31, 2014
Enrollment
656 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

fever